PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million

Reuters2026/08/13 20:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PetMed Express posts Q1 net loss of USD 6.1 million, or USD 0.28 per share, narrowing from a year earlier.
Net sales fall 19.9% year over year to USD 41 million on lower promotional usage and a decline in prescription medication sales.
Adjusted EBITDA (non-GAAP) loss widens to USD 3.4 million from a year earlier.
Technology transformation advances with an enterprise-wide rollout of a new SAP ERP system.
Marketing efficiency improves, adding 70,000 new customers while cutting new-customer acquisition cost 15% year over year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PetMed Express Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608131605PRIMZONEFULLFEED9809753) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million

You may also like

Crypto prices